Shingles Vaccine Given First Go-Ahead
Wednesday, March 01, 2006
The Food & Drug Administration (FDA) advisory panel has given tentative approval to a new vaccine, Zostavax, designed to prevent shingles in people 60 and older, saying it appears to be safe and effective for this age group. The panel has forwarded its recommendation to the FDA, which now has to decide whether to give final approval. The FDA usually follows its advisory panel recommendation.
Read More |
|